Dc-y13-27, a derivative of DC-Y13, is a potent YTHDF2 inhibitor (KD: 37.9 µM). DC-Y13-27 has antitumor activity that enhances the response of radiotherapy and immunotherapy to tumors.
Molecular Weight:
270.31
Purity:
99.83%
Formula:
C14H10N2O2S
Target:
MMP|||Others|||Interleukin|||Pyroptosis|||FOXO
T77764
T77764
* VAT and and shipping costs not included. Errors and price changes excepted
